Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease

Free Radical Biology and Medicine

Volumn 33, Issue 1, 2002, Pages 45-51

  Multhaup, Gerd ^a   Scheuermann, Stefan ^a   Schlicksupp, Andrea ^a   Simons, Andreas ^a   Strauss, Markus ^a   Kemmling, André ^a   Oehler, Christian ^a   Cappai, Roberto ^b   Pipkorn, Rüdiger ^c   Bayer, Thomas A ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Free radicals; Lipid peroxidation; Neurotoxicity; Transition metals

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COPPER ION; FREE RADICAL; ISOPROSTANE; ZINC ION; COPPER; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; CATALYSIS; DISEASE COURSE; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COPPER; HUMANS; LIPID PEROXIDATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 0036628728     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00806-7     Document Type: Article

References (92)

1. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
2. Protein oxidation in aging brain
3. Evidence of neuronal oxidative damage in Alzheimer's disease
4. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
5. Evidence of an oxidative challenge in the Alzheimer's brain
6. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease
7. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
8. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro
9. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
10. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease
11. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome
12. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease
13. Increased lipoprotein oxidation in Alzheimer's disease
14. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo
15. Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease
16. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus
17. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
18. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease
19. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
20. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
21. HWA 285 (propentofylline) - A new compound for the treatment of both vascular dementia and dementia of the Alzheimer type
22. Support of homeostatic glial cell signaling: A novel therapeutic approach by propentofylline
23. Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate
24. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress
25. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
26. Aging- and oxygen-induced modifications in brain biochemistry and behavior
27. Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization
28. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease
29. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis
30. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
31. Transgenic mice expressing Alzheimer amyloid precursor proteins
32. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF
33. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid
34. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
35. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
36. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies
37. Neurobiology of zinc and zinc-containing neurons
38. Evidence for release of copper in the brain: Depolarization-induced release of newly taken-up 67copper
39. Brain tissue accumulates 67copper by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process
40. Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability
41. Brain trace elements in Alzheimer's disease
42. Elemental imbalances in the olfactory pathway in Alzheimer's disease
43. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress
44. Copper, iron and zinc in Alzheimer's disease senile plaques
45. Regional brain trace-element studies in Alzheimer's disease
46. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain
47. An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease
48. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease
49. Rapid induction of Alzheimer A beta amyloid formation by zinc
50. Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors
51. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis
52. Aqueous dissolution of Alzheimer's disease abeta amyloid deposits by biometal depletion
53. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains
54. Histochemically reactive zinc in plaques of the swedish mutant beta-amyloid precursor protein transgenic mice
55. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease
56. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
57. Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins
58. The beta A4 amyloid precursor protein binding to copper
59. APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons
60. Analysis of pufferfish homologues of the AT-rich human APP gene
61. CDNA isolation of Alzheimer's amyloid precursor protein from cholinergic nerve terminals of the electric organ of the electric ray
62. Developmental regulation of Xenopus beta-amyloid precursor protein gene expression
63. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP)
64. Apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor
65. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor
66. Copper inhibits beta-amyloid production and stimulates the non- amyloidogenic pathway of amyloid-precursor-protein secretion
67. Differential effects of zinc on amyloid precursor protein (APP) processing in copper-resistant variants of cultured Chinese hamster ovary cells
68. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
69. Amyloid beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection
70. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein
71. The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix
72. Beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
73. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury
74. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation
75. Neurotrophic and neuroprotective effects of hAPP in transgenic mice
76. The Alzheimer's disease amyloid precursor protein (APP) modulates copper-induced toxicity and oxidative stress in primarya neuronal cultures
77. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
78. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
79. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice
80. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP)
81. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans
82. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
83. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
84. Reactive oxygen species and Alzheimer's disease
85. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide
86. Autoxidation of amyloid precursor protein and formation of reactive oxygen species
87. Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein
88. Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease
89. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I
90. Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae
91. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis
92. A novel action of alzheimer's amyloid beta-protein (Abeta): Oligomeric Abeta promotes lipid release